Detection and quantification of drug-specific T cells in penicillin allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 4, 2009, Pages 534-542

  Rozieres, A ^a,b,c,d   Hennino, A ^a,c   Rodet, K ^a,b,c   Gutowski, M C ^a   Gunera Saad, N ^a,b,c,d   Berard, F ^a,b,c,d   Cozon, G ^a,b,c,d   Bienvenu, J ^a,b,c,d   Nicolas, J F ^a,b,c,d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d University Lyon i   (France)

Author keywords

Delayed hypersensitivity; Enzyme linked immunospot assay; Interferon ; Penicillin allergy; T cell

Indexed keywords

AMOXICILLIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; TICARCILLIN;

ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG HYPERSENSITIVITY; DRUG SPECIFICITY; ENZYME LINKED IMMUNOSPOT ASSAY; GAMMA INTERFERON ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; PENICILLIN ALLERGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DRUG HYPERSENSITIVITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXANTHEMA; HUMANS; INFANT; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; PENICILLINS; SKIN DISEASES; SKIN TESTS; T-LYMPHOCYTES;

EID: 62449098612     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01674.x     Document Type: Article

References (41)

1. Gerber BO, Pichler WJ. Cellular mechanisms of T cell mediated drug hypersensitivity. Curr Opin Immunol 2004 16 : 732 737.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994 331 : 1272 1285.
3. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003 139 : 683 693.
4. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001 31 : 1398 1408.
5. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000 30 : 847 855.
6. Pirmohamed M, Naisbitt DJ, Gordon F, Park BK. The danger hypothesis - potential role in idiosyncratic drug reactions. Toxicology 2002 181-182 : 55 63.
7. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001 13 : 114 119.
8. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994 12 : 991 1045.
9. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998 134 : 1108 1112.
10. Heller HM. Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection. Clin Dermatol 2000 18 : 485 489.
11. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002 57 : 45 51.
12. Hug K, Yawalkar N, Helbling A, Pichler WJ. Scratch-patch and patch testing in drug allergy - an assessment of specificity. J Investig Allergol Clin Immunol 2003 13 : 12 19.
13. Torres MJ, Sanchez-Sabate E, Alvarez J, Mayorga C, Fernandez J, Padial A et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004 59 : 219 224.
14. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004 59 : 1153 1160.
15. Yoshimura T, Hamaguchi E, Usami E, Nakashima K, Kawaguchi M, Suzuki N et al. Increased in vitro release of interferon-gamma from ampicillin-stimulated peripheral blood mononuclear cells in Stevens-Johnson syndrome. Biol Pharm Bull 2004 27 : 929 931.
16. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988 110 : 29 36.
17. Tassignon J, Burny W, Dahmani S, Zhou L, Stordeur P, Byl B et al. Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR. J Immunol Methods 2005 305 : 188 198.
18. Schmittel A, Keilholz U, Scheibenbogen C. Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J Immunol Methods 1997 210 : 167 174.
19. Schmittel A, Keilholz U, Bauer S, Kuhne U, Stevanovic S, Thiel E et al. Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins. J Immunol Methods 2001 247 : 17 24.
20. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F et al. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 1999 189 : 779 786.
21. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D et al. CHS is mediated by early recruitment of CD8+ Tc1 cells. J Immunol 2002 168 : 3079 3087.
22. Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D et al. Allergic contact dermatitis. Eur J Dermatol 2004 14 : 284 295.
23. Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev 2003 196 : 247 264.
24. Matijevic M, Urban RG. Use of interferon-gamma ELISPOT in monitoring immune responses in humans. Methods Mol Biol 2005 302 : 237 252.
25. Beeler A, Engler O, Gerber BO, Pichler WJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006 117 : 455 462.
26. Devos SA, Van Der Valk PG. Epicutaneous patch testing. Eur J Dermatol 2002 12 : 506 513.
27. Pichler E, Fritsch P. Macular amelanotic melanoma in situ. Dermatologica 1988 177 : 313 316.
28. Kalish RS, LaPorte A, Wood JA, Johnson KL. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 1994 94 : 465 472.
29. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004 59 : 809 820.
30. Merk HF. Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 2005 209 : 217 220.
31. Padovan E. T-cell response in penicillin allergy. Clin Exp Allergy 1998 28 : 33 36.
32. Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998 110 : 203 206.
33. Cavani A, Mei D, Guerra E, Corinti S, Giani M, Pirrotta L et al. Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol 1998 111 : 621 628.
34. Erdmann SM, Heussen N, Moll-Slodowy S, Merk HF, Sachs B. CD63 expression on basophils as a tool for the diagnosis of pollen-associated food allergy: sensitivity and specificity. Clin Exp Allergy 2003 33 : 607 614.
35. Luque I, Leyva L, Jose Torres M, Rosal M, Mayorga C, Segura JM et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001 56 : 611 618.
36. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997 27 : 175 181.
37. Teraki Y, Shiohara T. IFN-gamma-producing effector CD8 + T cells and IL-10-producing regulatory CD4 + T cells in fixed drug eruption. J Allergy Clin Immunol 2003 112 : 609 615.
38. Naisbitt DJ, Farrell J, Chamberlain PJ, Hopkins JE, Berry NG, Pirmohamed M et al. Characterization of the T-cell response in a patient with phenindione hypersensitivity. J Pharmacol Exp Ther 2005 313 : 1058 1065.
39. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004 114 : 1209 1215.
40. Padial A, Posadas S, Alvarez J, Torres MJ, Alvarez JA, Mayorga C et al. Nonimmediate reactions to systemic corticosteroids suggest an immunological mechanism. Allergy 2005 60 : 665 670.
41. Shiohara T, Mizukawa Y. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007 17 : 201 208.